Evidence map›Paper›PMID 34882052›Full record

ArticleAnnals of medicine2021

Clinical outcomes, molecular epidemiology and resistance mechanisms of multidrug-resistant

Mazen A Sid Ahmed, Jemal M Hamid, Ahmed A Husain, Hamad Abdel Hadi, Sini Skariah, Ali A Sultan, Emad Bashir Ibrahim, Abdul Latif Al Khal, Bo Soderquist, Jana Jass and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Antimicrobial Treatment ofAntibiotics (Basel, Switzerland) · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Mazen A Sid AhmedDepartment of Pathology and Laboratory Medicine, Division of Microbiology, Hamad Medical Corporation, Doha, Qatar.ORCID 0000-0002-6186-7770
Jemal M HamidDepartment of Pathology and Laboratory Medicine, Division of Microbiology, Hamad Medical Corporation, Doha, Qatar.
Ahmed A HusainDepartment of Medicine, Division of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Hamad Abdel HadiDepartment of Medicine, Division of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Sini SkariahDepartment of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar.
Ali A SultanDepartment of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar.
Emad Bashir IbrahimDepartment of Pathology and Laboratory Medicine, Division of Microbiology, Hamad Medical Corporation, Doha, Qatar.
Abdul Latif Al KhalDepartment of Medicine, Division of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Bo SoderquistSchool of Medical Sciences, Faculty of Medicine and Health, Orebro University, Orebro, Sweden.
Jana JassThe Life Science Centre, School of Science and Technology, Örebro University, Örebro, Sweden.
Ali S OmraniDepartment of Medicine, Division of Infectious Diseases, Hamad Medical Corporation, Doha, Qatar.
Hamad Medical Corporation · QAÖrebro University · SEWeill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBloodstream infections (BSIs) caused by multidrug-resistant (MDR)- MATERIALS AND

methodsWe included all MDR-

resultsOut of 362

conclusionMDR-

Indexed as

Pseudomonas InfectionsSepsisAdultAgedAged, 80 and overAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsMiddle AgedMolecular EpidemiologyPseudomonas aeruginosaQatarAnti-Bacterial AgentsBacteraemiaMDRPseudomonas aeruginosaQatar

Identifiers

PMID34882052
PMCPMC8667892
OpenAlexW4200271406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.